Details of the Drug

General Information of Drug (ID: DMH3T2E)

Drug Name

Triplex

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05099965) Phase II, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex?), in Adults With Both Human Immunodeficiency Virus (HIV)-1 and CMV Who Are on Potent Combination ART With Conserved Immune Function. U.S.National Institutes of Health.